Disclosure Panels Details Page
Pancreatic Adenocarcinoma Panel - Disclosures as of 01/31/2019
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mahmoud Al-Hawary MD | None | None | None | None | - |
| Horacio Asbun MD | None | None | None | None | - |
| Stephen Behrman MD | None | None | None | None | ✔ |
| Al Benson III MD, FACCC, FACP, FASCO | Acerta Pharma Amgen Inc. Astellas Pharma US, Inc. Bristol-Myers Squibb Company Celgene Corporation Infinity Pharmaceuticals, Inc MedImmune Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Taiho Pharmaceuticals Co., Ltd. |
Astellas Pharma US, Inc. Bayer HealthCare Bristol-Myers Squibb Company Eli Lilly and Company Exelixis Inc. Genentech, Inc. Merck & Co., Inc. Purdue Pharma LP Taiho Pharmaceuticals Co., Ltd. |
None | None | ✔ |
| Ellen Binder MD | Astellas Pharma US, Inc. | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | ✔ |
| Dana Cardin MD | None | Raphael Pharma | AbbVie, Inc. | None | ✔ |
| Charles Cha MD | None | None | None | None | ✔ |
| Elena Chiorean MD | Boehringer Ingelheim GmbH Celgene Corporation Eli Lilly and Company Incyte Corporation Merck & Co., Inc. Roche Laboratories, Inc. |
AstraZeneca Pharmaceuticals LP Eisai Inc. Halozyme, Inc. Ipsen Seattle Genetics, Inc. |
None | None | ✔ |
| Vincent Chung MD | None | Ipsen Perthera |
Celgene Corporation Ipsen |
None | - |
| Brian Czito MD | AbbVie, Inc. Oakstone Varian Medical Systems, Inc. |
None | Varian Medical Systems, Inc. | None | - |
| Marco Del Chiaro MD, PhD | Boston Scientific Corporation | Immunovia, AB | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | Decision Resources Group Consulting | None | None | ✔ |
| Mary Dillhoff MD, MS | None | None | None | None | ✔ |
| Efrat Dotan MD | Boston Biomedical GlaxoSmithKline Incyte Corporation MedImmune Inc. Merck & Co., Inc. Pfizer Inc. |
ARMO Biosciences Boston Biomedical |
None | None | - |
| Cristina Ferrone MD | None | None | None | None | - |
| George Fisher MD, PhD | Forty Seven, Inc. Genentech, Inc. Merck & Co., Inc. Roche Laboratories, Inc. |
None | None | None | ✔ |
| Christos Fountzilas MD | Astellas Pharma US, Inc. BeiGene Boston Biomedical Bristol-Myers Squibb Company Eli Lilly and Company MedImmune Inc. Merck & Co., Inc. Merrimack National Cancer Institute Taiho Pharmaceuticals Co., Ltd. |
AstraZeneca Pharmaceuticals LP | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Jeffrey Hardacre MD | None | None | None | None | ✔ |
| William Hawkins MD | Accuronix | None | Accuronix therapeutics | None | - |
| Kyle Herrmann BSN, RN, OCN | None | None | None | None | - |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Andrew Ko MD | None | Abgenomics Apexigen ARMO Biosciences AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Celgene Corporation Genentech, Inc. Gilead Sciences, Inc. Halozyme, Inc. Merck & Co., Inc. Merrimack Pharmacyclics Rafael Pharmaceuticals Two Pore Guys Vicus |
None | None | ✔ |
| Noelle LoConte MD | None | AbbVie, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Celgene Corporation |
None | None | ✔ |
| Andrew Lowy MD | Halozyme, Inc. | Bexion Inc Fount Pfizer Inc. |
None | None | ✔ |
| Mokenge Malafa MD, FACS | None | None | None | None | - |
| Cassadie Moravek BS | None | None | None | None | - |
| Eric Nakakura MD | None | Expert witness: review medical records for law fims and provide opinion of care provided | None | None | - |
| Amol Narang MD | Boston Scientific Corporation | None | None | None | ✔ |
| Jorge Obando MD | None | Boston Scientific Corporation Merck & Co., Inc. Pfizer Inc. Poyner Spruill Law firm |
None | None | - |
| Eileen O'Reilly MD | None | Aptus Bioline Bristol-Myers Squibb Company Celgene Corporation CytomX Gilead Sciences, Inc. Halozyme Janssen Pharmaceutica Products, LP Loxo Newlink Genetics Pfizer Inc. Pharmacy Pharmacyclics Pieris sanofi-aventis U.S. Silenseed Sobi Targovax Twoxar |
None | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Sushanth Reddy MD | None | None | None | None | ✔ |
| Courtney Scaife MD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Margaret Tempero MD | None | AbbVie, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP BioPharm Communications Bristol-Myers Squibb Company Celgene Corporation CPRIT Eisai Inc. Halozyme, Inc. Ignyta, Inc. Immunovia Pharmacyclics Tocagen, Inc. |
None | None | ✔ |
| Sarah Thayer MD, PhD | ScreenCell | ScreenCell | None | None | ✔ |
| Robert Wolff MD | None | None | None | None | ✔ |
| Brian Wolpin MD, MPH | Celgene Corporation | BioLineRx Grail |
None | None | ✔ |
| Griselda Zuccarino-Catania PhD | None | None | None | Janssen Pharmaceutica Products, LP | ✔ |